44 results
Page 2 of 3
6-K
EX-1.1
7j83g4wi
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
F-1/A
EX-1.1
dlxjdwivbdxug5
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-4.4
5ma8fnluu
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-4.6
3m4t2f kibsh5lzzmvr8
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-1.1
no31yt1u0c yvuuk05
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.3
iq9dt
1 Jul 20
Report of Foreign Private Issuer
9:05am
F-1/A
EX-4.7
cq9l2rej2b9 vzr
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
EX-4.7
np6 jq33l
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
EX-4.7
6vkde79w azw3o0
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
424B5
vaysmo ai
5 Dec 19
Prospectus supplement for primary offering
5:29pm
424B5
a8n12
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
EX-10.1
hccyv8 rb4c
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
EX-99.1
ei08l4hfxekhnifqy6q
28 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:27am
6-K
EX-10.3
h71mp5f7qm8hwf5528f
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
6-K
EX-10.1
2fi60td tdd6i
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
424B2
m15voreb8 cvm2k47zn
9 Aug 18
Prospectus for primary offering
11:19am
F-3/A
3w0qi
17 Jul 18
Shelf registration (foreign) (amended)
1:29pm